Collectively, these results support a crucial role of the ERRα-CPT1C pathway in the anti-tumor effect of miR-1291, and suggest a new anticancer strategy involving the miR-1291-ERRα-CPT1C axis. This evidence concerns the gene ESRRA and neoplasm.